Stimulation_NN
of_IN
a_DT
human_JJ
T-cell_NN
clone_NN
with_IN
anti-CD3_NN
or_CC
tumor_NN
necrosis_NN
factor_NN
induces_VBZ
NF-kappa_NN
B_NN
translocation_NN
but_CC
not_RB
human_JJ
immunodeficiency_NN
virus_NN
1_CD
enhancer-dependent_JJ
transcription_NN
._.

The_DT
expression_NN
of_IN
transiently_RB
transfected_VBN
expression_NN
vectors_NNS
under_IN
the_DT
control_NN
of_IN
the_DT
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
of_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
or_CC
its_PRP$
enhancer_NN
sequence_NN
and_CC
the_DT
translocation_NN
of_IN
the_DT
HIV_NN
enhancer-binding_JJ
protein_NN
NF-kappa_NN
B_NN
were_VBD
analyzed_VBN
in_IN
two_CD
human_JJ
T-cell_NN
clones_NNS
stimulated_VBN
through_IN
their_PRP$
T-cell_NN
receptor_NN
complex_NN
or_CC
by_IN
tumor_NN
necrosis_NN
factor_NN
or_CC
phorbol_NN
12-myristate_NN
13-acetate_NN
._.

We_PRP
found_VBD
a_DT
dissociation_NN
of_IN
NF-kappa_NN
B_NN
translocation_NN
from_IN
transactivation_NN
of_IN
either_CC
the_DT
HIV_NN
LTR_NN
or_CC
the_DT
HIV_NN
enhancer_NN
._.

Interleukin_NN
2_CD
induced_VBD
proliferation_NN
but_CC
not_RB
NF-kappa_NN
B_NN
translocation_NN
or_CC
LTR_NN
transactivation_NN
._.

Phorbol_NN
ester_NN
or_CC
specific_JJ
antigen_NN
recognition_NN
induced_VBD
HIV_NN
LTR_NN
transactivation_NN
,_,
whereas_IN
stimulation_NN
with_IN
tumor_NN
necrosis_NN
factor_NN
or_CC
antibody_NN
to_TO
CD3_NN
did_VBD
not_RB
._.

The_DT
two_CD
latter_JJ
signals_NNS
were_VBD
nevertheless_RB
able_JJ
to_TO
induce_VB
NF-kappa_NN
B_NN
translocation_NN
with_IN
a_DT
pattern_NN
in_IN
the_DT
band-shift_JJ
assay_NN
indistinguishable_JJ
from_IN
that_DT
observed_VBN
using_VBG
phorbol_NN
ester_NN
._.

Our_PRP$
finding_NN
that_IN
induction_NN
of_IN
NF-kappa_NN
B_NN
by_IN
tumor_NN
necrosis_NN
factor_NN
or_CC
antibody_NN
to_TO
CD3_NN
is_VBZ
not_RB
sufficient_JJ
to_TO
induce_VB
HIV_NN
enhancer-dependent_JJ
transcription_NN
in_IN
cloned_VBN
T_NN
cells_NNS
contrasts_VBZ
with_IN
results_NNS
obtained_VBN
in_IN
most_JJS
lymphoblastoid_JJ
T-cell_NN
lines_NNS
and_CC
indicates_VBZ
that_IN
normal_JJ
T_NN
lymphocytes_NNS
differ_VBP
from_IN
tumoral_JJ
T_NN
cells_NNS
in_IN
terms_NNS
of_IN
requirements_NNS
for_IN
HIV_NN
LTR_NN
activation_NN
._.

Furthermore_RB
,_,
our_PRP$
results_NNS
suggest_VBP
that_IN
events_NNS
linked_VBN
to_TO
T-cell_NN
activation_NN
,_,
in_IN
addition_NN
to_TO
NF-kappa_NN
B_NN
translocation_NN
per_FW
se_FW
,_,
induce_VBP
functional_JJ
interactions_NNS
of_IN
the_DT
NF-kappa_NN
B_NN
complex_NN
with_IN
the_DT
HIV_NN
enhancer_NN
._.

